Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Wilding

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Global Health Action|August 25, 2020
Strengthening resistance to the COVID-19 pandemic and fostering future resilience requires concerted action on obesityAngela M Jackson-Morris, Rachel Nugent, Johanna Ralston, et al.
Current Obesity Reports|November 18, 2021
Exercise in Obesity-the Role of Technology in Health Services: Can This Approach Work?Laurence J Dobbie, Abd Tahrani, Uazman Alam, et al.
Endocrinology|December 17, 2008
Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytesQi Ding, Tomas Mracek, Pedro Gonzalez-Muniesa, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metforminJan Bolinder, Östen Ljunggren, Joel Kullberg, et al.
Diabetes, Obesity & Metabolism|August 4, 2020
Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidencePhil McEwan, Hayley Bennett, Kamlesh Khunti, et al.
BMJ Open|September 14, 2025
Rising to the challenges of research in multiple long-term conditions: health and social care research ecosystem approachesAnthony De Soyza, Victoria A Goodwin, Kate Roberts, et al.
BMC Medicine|July 17, 2018
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research DatalinkJohn Wilding, Thomas Godec, Kamlesh Khunti, et al.
Journal of Obesity|October 18, 2016
Altered Left Ventricular Ion Channel Transcriptome in a High-Fat-Fed Rat Model of Obesity: Insight into Obesity-Induced ArrhythmogenesisReza Ashrafi, Marianne Yon, Lucy Pickavance, et al.
BMJ Open Diabetes Research & Care|October 29, 2020
Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse eventsIldiko Lingvay, Thomas Hansen, Stanislava Macura, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|January 11, 2011
Charting the developmental trajectories of attention and executive function in Chinese school-aged childrenJian-Ying Zhan, John Wilding, Kim Cornish, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Global Health Action|August 25, 2020
Strengthening resistance to the COVID-19 pandemic and fostering future resilience requires concerted action on obesityAngela M Jackson-Morris, Rachel Nugent, Johanna Ralston, et al.
Current Obesity Reports|November 18, 2021
Exercise in Obesity-the Role of Technology in Health Services: Can This Approach Work?Laurence J Dobbie, Abd Tahrani, Uazman Alam, et al.
Endocrinology|December 17, 2008
Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytesQi Ding, Tomas Mracek, Pedro Gonzalez-Muniesa, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metforminJan Bolinder, Östen Ljunggren, Joel Kullberg, et al.
Diabetes, Obesity & Metabolism|August 4, 2020
Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidencePhil McEwan, Hayley Bennett, Kamlesh Khunti, et al.
BMJ Open|September 14, 2025
Rising to the challenges of research in multiple long-term conditions: health and social care research ecosystem approachesAnthony De Soyza, Victoria A Goodwin, Kate Roberts, et al.
BMC Medicine|July 17, 2018
Changes in HbA1c and weight, and treatment persistence, over the 18 months following initiation of second-line therapy in patients with type 2 diabetes: results from the United Kingdom Clinical Practice Research DatalinkJohn Wilding, Thomas Godec, Kamlesh Khunti, et al.
Journal of Obesity|October 18, 2016
Altered Left Ventricular Ion Channel Transcriptome in a High-Fat-Fed Rat Model of Obesity: Insight into Obesity-Induced ArrhythmogenesisReza Ashrafi, Marianne Yon, Lucy Pickavance, et al.
BMJ Open Diabetes Research & Care|October 29, 2020
Superior weight loss with once-weekly semaglutide versus other glucagon-like peptide-1 receptor agonists is independent of gastrointestinal adverse eventsIldiko Lingvay, Thomas Hansen, Stanislava Macura, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|January 11, 2011
Charting the developmental trajectories of attention and executive function in Chinese school-aged childrenJian-Ying Zhan, John Wilding, Kim Cornish, et al.
Pageof 8